These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Octreotide (SMS 201-995) for hematopoietic support-dependent high-dose chemotherapy (HSD-HDC)-related diarrhoea: dose finding study and evaluation of efficacy. Wasserman E, Hidalgo M, Hornedo J, Cortés-Funes H. Bone Marrow Transplant; 1997 Nov 27; 20(9):711-4. PubMed ID: 9384471 [Abstract] [Full Text] [Related]
14. Eosinophilic gastroenteritis with severe protein-losing enteropathy: successful treatment with budesonide. Siewert E, Lammert F, Koppitz P, Schmidt T, Matern S. Dig Liver Dis; 2006 Jan 27; 38(1):55-9. PubMed ID: 16326154 [Abstract] [Full Text] [Related]
15. Benefit of ketotifen in patients with eosinophilic gastroenteritis. Melamed I, Feanny SJ, Sherman PM, Roifman CM. Am J Med; 1991 Mar 27; 90(3):310-4. PubMed ID: 2003512 [Abstract] [Full Text] [Related]
17. Efficacy of octreotide but not long-acting somatostatin analogue for severe refractory diabetic diarrhoea. Corbould A, Campbell J. Diabet Med; 2009 Aug 27; 26(8):828-9. PubMed ID: 19709156 [No Abstract] [Full Text] [Related]